Letter by Dai et al regarding article, "Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial".
作者信息
Dai Qiliang, Sun Wen, Liu Xinfeng
机构信息
Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
出版信息
Stroke. 2014 Jul;45(7):e132. doi: 10.1161/STROKEAHA.114.005857. Epub 2014 Jun 10.
PMID:24916904
Abstract
摘要
相似文献
1
Letter by Dai et al regarding article, "Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial".
Stroke. 2014 Jul;45(7):e132. doi: 10.1161/STROKEAHA.114.005857. Epub 2014 Jun 10.
2
Response to letter regarding article, "Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial".
Stroke. 2014 Jul;45(7):e133. doi: 10.1161/STROKEAHA.114.005871. Epub 2014 Jun 10.
3
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?
Stroke. 2004 May;35(5):1141-6. doi: 10.1161/01.STR.0000125712.02090.6e. Epub 2004 Apr 15.
4
Prognostic Parameters for Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in an Asian Population.
Curr Neurovasc Res. 2017;14(2):169-176. doi: 10.2174/1567202614666170327163905.
5
Early deterioration after thrombolysis plus aspirin in acute stroke: a post hoc analysis of the Antiplatelet Therapy in Combination with Recombinant t-PA Thrombolysis in Ischemic Stroke trial.
Stroke. 2014 Oct;45(10):3080-2. doi: 10.1161/STROKEAHA.114.006268. Epub 2014 Aug 19.
6
Utilization of lysis percentage via thromboelastography for tissue plasminogen activator-induced symptomatic intracranial hemorrhage.
Am J Emerg Med. 2021 May;43:31-34. doi: 10.1016/j.ajem.2021.01.034. Epub 2021 Jan 16.
7
Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Drug Des Devel Ther. 2017 May 18;11:1559-1566. doi: 10.2147/DDDT.S133759. eCollection 2017.
8
Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis.
Int J Stroke. 2015 Dec;10(8):1224-8. doi: 10.1111/ijs.12626. Epub 2015 Aug 26.
9
Treatment patterns and short-term outcomes in ischemic stroke in pregnancy or postpartum period.
Am J Obstet Gynecol. 2016 Jun;214(6):723.e1-723.e11. doi: 10.1016/j.ajog.2015.12.016. Epub 2015 Dec 18.
10
Reperfusion trials for acute ischaemic stroke.
Lancet. 2012 Aug 25;380(9843):706-8. doi: 10.1016/S0140-6736(12)61043-5. Epub 2012 Jun 28.
引用本文的文献
1
Response to letter regarding article, "Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial".
Stroke. 2014 Jul;45(7):e133. doi: 10.1161/STROKEAHA.114.005871. Epub 2014 Jun 10.
Zotero 插件